South Staffordshire Joint FormularyCannock Chase Clinical Commissioning Group East Staffordshire Clinical Commissioning Group South East Staffordshire and Seisdon Peninsula Clinical Commissioning Group Stafford and Surrounds Clinical Commissioning Group
For patients with COPD who are classified in Gold category D and found to be suitable, upon patient assessment, for triple therapy with ICS/LABA and LAMA. This provides a cost effective option to have this treatment as one inhaler.
Budesonide/formoterol (DuoResp Spiromax) (Prescribe by BRAND)
For ASTHMA ONLY. NOT to be used for anyone under the age of 18. In asthma, the 160/4.5 inhaler may be used both as regular maintenance treatment and as needed in response to symptoms.
The 320/9 inhaler must be used with a separate reliever.